EP3097121
Mótefnasameindir við PD-1 og notagildi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.1.2015EP published:
19.12.2018EP application number:
15703384.6
EP translation filed:
18.3.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
22.1.2035Expiry date:
22.1.2025
Title:
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
Timeline
Today
23.1.2015EP application
19.12.2018EP Publication
18.3.2019Translation submitted
15.4.2019Registration published
22.1.2025Expires
Owner
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, 02115-5450, Boston, MA, US
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Name:
President and Fellows of Harvard CollegeAddress:
17 Quincy Street, 02138, Cambridge, MA, US
Inventor
Name:
FREEMAN, Gordon, JamesAddress:
Brookline, MA, US
Name:
SHARPE, Arlene, HelenAddress:
Brookline, MA, US
Name:
BLATTLER, Walter, A.Address:
Brookline, MA, US
Name:
MATARAZA, Jennifer, MarieAddress:
Brookline, MA, US
Name:
SABATOS-PEYTON, Catherine, AnneAddress:
Newton, MA, US
Name:
CHANG, Hwai, WenAddress:
San Marcos, CA, US
Name:
FREY, Gerhard, JohannAddress:
San Diego, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461931512 PDate:
24.1.2014Country:
US
Number:
201462059676 PDate:
3.10.2014Country:
US
Number:
201462094834 PDate:
19.12.2014Country:
US
Classification
Categories:
C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.3.2019
Expires: 22.1.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 6
Paid: 31.12.2019
Expires: 22.1.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 29.12.2020
Expires: 22.1.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.12.2021
Expires: 22.1.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 22.12.2022
Expires: 22.1.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 27.12.2023
Expires: 22.1.2025
Payer: Árnason Faktor ehf.